New Data Show NEXTSTELLIS® Has Selective Impact On Endocrine Markers Compared With Common Combined Oral Contraceptives
RALEIGH, N.C., March 6, 2021 /PRNewswire/ — Mayne Pharma announced today new data showing treatment with NEXTSTELLIS®,1 a novel, investigational combined…